Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India

 Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it has received regulatory approval to expand enrollment of its … Read More

TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei’s efficacy at an unprecedented level in weight loss and satiety

The French biotech TargEDys specialized in breakthrough microbiome-based solutions announces the publication of its study conducted in 230 overweight adults supplemented for 12 weeks, confirming the efficacy of the precision … Read More

Pharma accelerating new partnership development at CPhI Discover ahead of returning in-person events

Amsterdam: The second week ofCPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both … Read More

Microba Life Sciences and Illumina partner to accelerate microbiome research

Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies to advance understanding of the … Read More

Global Vaccine Raw Material Demand is Rapidly Growing | Top Companies statistics, Emerging Trends, Supply and Demand, Country wise Opportunity and Research Report to 2021, Says Brandessence Market Research

PUNE– Brandessence Market Research has published a new report title” Global Vaccine Raw Material Market Size By Applications (Covid-19, Smallpox, Influenza, Measles, Mumps, Rubella, Polio, TB, Others), By End-User (Research Institute, Vaccine … Read More

Biopharmaceuticals Market to Reach USD 113,300 Million by 2026 at CAGR 4.7% – Valuates Reports

The Biopharmaceuticals Market is Segmented by Type (Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin , Insulin, Vaccines, Growth Hormones, Others), by Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Others). The report covers global opportunity analysis and industry forecast from 2021 … Read More

Glenmark’s Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in … Read More